Abstract
Computerized administration of neuropsychological tests can be an objective, sensitive and efficient way to screen for and monitor cognitive changes in the elderly. However, current computer software still suffers from limitations in both the administration of those tests and the interpretation of their results, which might severely hamper their usability. In this paper qualitative aspects of current methods and their use in the prediction of dementia are discussed, guidelines for correct design and usage of computerized methods are suggested and a solution that overcomes several of the methodological limitations is proposed.
Keywords: Computerized neuropsychological test, human-computer interaction, mild cognitive impairment, dementia, neuropsychological tests, Alzheimer prediction
Current Alzheimer Research
Title: Computerized Methods in the Assessment and Prediction of Dementia
Volume: 4 Issue: 4
Author(s): Amos D. Korczyn and Vered Aharonson
Affiliation:
Keywords: Computerized neuropsychological test, human-computer interaction, mild cognitive impairment, dementia, neuropsychological tests, Alzheimer prediction
Abstract: Computerized administration of neuropsychological tests can be an objective, sensitive and efficient way to screen for and monitor cognitive changes in the elderly. However, current computer software still suffers from limitations in both the administration of those tests and the interpretation of their results, which might severely hamper their usability. In this paper qualitative aspects of current methods and their use in the prediction of dementia are discussed, guidelines for correct design and usage of computerized methods are suggested and a solution that overcomes several of the methodological limitations is proposed.
Export Options
About this article
Cite this article as:
Korczyn D. Amos and Aharonson Vered, Computerized Methods in the Assessment and Prediction of Dementia, Current Alzheimer Research 2007; 4 (4) . https://dx.doi.org/10.2174/156720507781788954
DOI https://dx.doi.org/10.2174/156720507781788954 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Hesperidin in Cell Signal Transduction Pathway for the Prevention or Treatment of Cancer
Current Medicinal Chemistry Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer’s Disease Patients
Current Alzheimer Research Platelets in Alzheimer’s Disease-Associated Cellular Senescence and Inflammation
Current Pharmaceutical Design The Interrelationship Between Disease and Ageing and the Implications for Longevity
Current Aging Science Editorial [Hot Topic New Clinical Indications of Antipsychotic Medications Guest Editors: Filippo Bogetto and Silvio Bellino]
Current Psychopharmacology The Infectious Etiology of Alzheimer’s Disease
Current Neuropharmacology Stroke Prevention: From Available Antiplatelet Drugs to Novel Molecular Targets
Current Drug Targets Cutting through the Complexities of mTOR for the Treatment of Stroke
Current Neurovascular Research Total Bakkenolides Protects Neurons Against Cerebral Ischemic Injury Through Inhibition of Nuclear Factor-κB Activation
CNS & Neurological Disorders - Drug Targets Elicitation of Immune Responsiveness Against Antigenic Challenge in Age- Related Diseases: Effects of Red Wine Polyphenols
Current Pharmaceutical Design IL-3 Control Tau Modifications and Protects Cortical Neurons from Neurodegeneration
Current Alzheimer Research Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Renal Complications of Fabry Disease
Current Pharmaceutical Design Cerebrovascular Diseases in HIV-Infected Patients
Current HIV Research Neuroprotective Strategies for Parkinsons Disease
Current Neuropharmacology The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy
Current Pharmaceutical Design Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology Cell Microencapsulation Implants into the Central Nervous System
Recent Patents on Nanomedicine Lipids as Key Players in Alzheimer Disease - Alterations in Metabolism and Genetics
Current Alzheimer Research Editorial (New Wave from Immunology, Endocrine & Metabolic Agents in Medicinal Chemistr )
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)